During the past decade, Klinikum Passau, II. Medizinische Klinik conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Passau, II. Medizinische Klinik" are "Chronic Myeloid Leukemia" (1 trials), "Colorectal Cancer" (1 trials) and "Liver Metastases" (1 trials). Many other conditions were trialed in "Klinikum Passau, II. Medizinische Klinik" in a lesser frequency.

Most popular intervention types in "Klinikum Passau, II. Medizinische Klinik" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (1 trials), "Cetuximab and FOLFIRI" (1 trials), "Cetuximab and FOLFOX" (1 trials), "Liver resection" (1 trials) and "Nilotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Passau, II. Medizinische Klinik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Passau, II. Medizinische Klinik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Passau, II. Medizinische Klinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Passau, II. Medizinische Klinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".